Long COVID increases costs of primary care consultations each year

Data from almost a million patient healthcare records show at least £23m extra bill for GP appointments 12 weeks after Covid diagnosis

Close up picture of a doctor taking notes by hand during an appointment

Long COVID is estimated to have cost the UK at least an extra £23 million in GP and other primary care consultations each year, according to a new study.

The analysis of the economic impact of Long Covid, or Post COVID-19 Condition, has been published in BMC Primary Care, and considers more than 950,000 electronic healthcare records following the start of the global Covid-19 pandemic.

The research team led by the University of Birmingham and funded by a grant from the National Institute for Health and Care Research and UKRI calculated that the additional cost for primary care consultations more than 12 weeks after a Covid-19 infection was £2.44, and that the impact of Long Covid may increase these costs significantly to £30 per patient diagnosed with Long COVID and £57 per patient for those with ongoing symptoms. The team conclude that the additional financial cost for primary care services associated with consultations across the UK could be over £23m per year.

These costs represent only a part of the overall increase in healthcare resources needed to support people with Long COVID

Dr Louise Jackson

Dr Louise Jackson from the Health Economics Unit at the University of Birmingham and co-lead author of the study said:

“Covid-19 has led to a significant increase in the need for primary care services. As a result, the financial burden of people getting Long Covid is estimated to be between £23m and £60m per year in additional consultations from GPs, nurses, and other health practitioners.

“These costs represent only a part of the overall increase in healthcare resources needed to support people with Long COVID and should be considered in future pandemic planning.”

 

At risk groups

 

Some patients who are at greater risk of having Long Covid are more likely to need additional care, the study also found.

Other factors that were found to increase primary care costs among people at least 12 weeks after a Covid infection included:

  • Older patients
  • Female patients
  • Ethnically white patients
  • Patients with obesity
  • Having long-term health conditions.

Dr Shamil Haroon from the Institute of Applied Health Research at the University of Birmingham and co-lead author of the study said:

“We have tried to calculate how much we need to support people with Long Covid in our healthcare system, as we know that many people have ongoing health issues following an infection.

“Using data from the earliest parts of the pandemic, we have been able to look at a balanced sample size of those who have had Covid and those who hadn’t. These data show that the economic impact on primary care after Covid is not being felt equally in different communities and that access to care may vary among different parts of the population. We might expect that patients who are older or who have long-term health conditions will need additional primary care support, but we have also seen additional costs associated with being white and female.

“Long Covid as a condition also continues to be poorly understood and underdiagnosed. It’s very likely that additional consultation time and resources have been needed for patients with Long Covid who don’t have a formal diagnosis.”

Notes for editors

  • For media enquiries please contact Tim Mayo, Press Office, University of Birmingham, tel: +44 (0)7920 405040.
  • The University of Birmingham is ranked amongst the world’s top 100 institutions. Its work brings people from across the world to Birmingham, including researchers, teachers and more than 8,000 international students from over 150 countries.

  • The University of Birmingham is a founding member of Birmingham Health Partners (BHP), a strategic alliance which transcends organisational boundaries to rapidly translate healthcare research findings into new diagnostics, drugs and devices for patients. Birmingham Health Partners is a strategic alliance between seven organisations who collaborate to bring healthcare innovations through to clinical application:
    • University of Birmingham
    • University Hospitals Birmingham NHS Foundation Trust
    • Birmingham Women's and Children's Hospitals NHS Foundation Trust
    • Aston University
    • The Royal Orthopaedic Hospital NHS Foundation Trust
    • Sandwell and West Birmingham Hospitals NHS Trust
    • West Midlands Academic Health Science Network
    • Birmingham and Solihull Mental Health NHS Foundation Trust

 

About the National Institute for Health and Care Research

The mission of the National Institute for Health and Care Research (NIHR) is to improve the health and wealth of the nation through research. We do this by:

  • Funding high quality, timely research that benefits the NHS, public health and social care;
  • Investing in world-class expertise, facilities and a skilled delivery workforce to translate discoveries into improved treatments and services;
  • Partnering with patients, service users, carers and communities, improving the relevance, quality and impact of our research;
  • Attracting, training and supporting the best researchers to tackle complex health and social care challenges;
  • Collaborating with other public funders, charities and industry to help shape a cohesive and globally competitive research system;
  • Funding applied global health research and training to meet the needs of the poorest people in low and middle income countries.

NIHR is funded by the Department of Health and Social Care. Its work in low and middle income countries is principally funded through UK Aid from the UK government.